A Takeda spokesperson told Fierce Biotech that it was on track to open its new R&D facility being developed by BioMed Realty ...
Following Moderna's public rebuke of the FDA's refusal to take up its application for a next-gen flu vaccine, the regulator has doubled down and accused Moderna of potentially putting patients at risk ...
Madrigal Pharmaceuticals is continuing to splash the cash this year on liver disease drugs it can combine with its own potential blockbuster Rezdiffra. | Madrigal Pharmaceuticals is continuing to ...
A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma exacerbation ...
GE HealthCare has launched a new technology designed to help hospitals keep up with the maintenance and repair demands of a growing number of connected medical devices. | GE HealthCare has launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results